key: cord-307622-r23eebet
authors: Kass, David A; Duggal, Priya; Cingolani, Oscar
title: Obesity could shift severe COVID-19 disease to younger ages
date: 2020-05-04
journal: Lancet
DOI: 10.1016/s0140-6736(20)31024-2
sha: 
doc_id: 307622
cord_uid: r23eebet

nan

Obesity could shift severe COVID-19 disease to younger ages C o r o n a v i r u s d i s e a s e 2 0 1 9 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 was first reported in China in late December, 2019, and has since evolved into a global pandemic. As of April 29, 2020, COVID-19 has been confirmed in more than 3 million individuals in 185 countries and regions, with an overall mortality rate of more than 6%. 1 Severe disease involves bilateral interstitial pneumonia requiring intensive care unit (ICU) ventilatory support and can evolve into adult respiratory distress syndrome with high mortality. The largest study of 1591 ICU patients from Italy reported a median age of 63 years, with only 203 patients (13%) younger than 51 years. 2 Common comorbidities are hypertension, cardiovascular disease, type 2 diabetes, and, more rarely (42 [4%] of 1043), obstructive pulmonary disease. Similar data have been reported from China. 3 When the COVID-19 epidemic began in the USA, we anticipated a similar ICU population. News reports and communications from the US Federal Government had emphasised that COVID-19 was a particular problem for older people, and a resistance to social distancing and sheltering in place by younger people might have been informed by this idea. However, as the pandemic hit the Johns Hopkins Hospital in late March, 2020, younger patients began to be admitted to our ICU, many of whom were also obese. An informal survey of colleagues directing ICUs at other hospitals around the country yielded similar findings. At this time, news editorials were noting obesity as an underappreciated risk factor for COVID-19. 4 This risk is particularly relevant in the USA because the prevalence of obesity is around 40%, versus a prevalence of 6·2% in China, 20% in Italy, and 24% in Spain. 5

With use of least squares univariate and multivariate linear regression, we examined the correlation between body-mass index (BMI) and age in patients with COVID-19 admitted to ICU at university hospitals at Johns Hopkins, University of Cincinnati, New York University, University of Washington, Florida Health, and University of Pennsylvania (appendix). Acquisition of the de-identified data for this analysis was approved by the Johns Hopkins University Institutional Review Board.

In our dataset of 265 patients (58% male patients), we found a significant inverse correlation between age and BMI, in which younger individuals admitted to hospital were more likely to be obese (figure). There was no difference by sex (p=0·9). The median BMI was 29·3 kg/m², with only 25% of individuals having a BMI of less than 26 kg/m², and 25% exceeding a BMI of 34·7 kg/m². Obesity can restrict ventilation by impeding diaphragm excursion, impairs immune responses to viral infection, 6 is pro-inflammatory, and induces diabetes and oxidant stress to adversely affect cardiovascular function. 7 We conclude that in populations with a high prevalence of obesity, COVID-19 will affect younger populations more than previously reported. Public messaging to younger adults, reducing the threshold for virus testing in obese individuals, and maintaining greater vigilance for this at-risk population should reduce the prevalence of severe COVID-19 disease. 

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Americans are already too diseased to go back to work right now

Global Health Obsevatory (GHO) data: overweight and obesity

Impact of obesity on influenza A virus pathogenesis, immune response, and evolution